Alivus Life Sciences (NSE:ALIVUS) FCF Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alivus Life Sciences's Free Cash Flow for the three months ended in Dec. 2024 was ₹0 Mil. Alivus Life Sciences's Revenue for the three months ended in Dec. 2024 was ₹6,418 Mil. Therefore, Alivus Life Sciences's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Alivus Life Sciences's current FCF Yield % is 2.28%.

The historical rank and industry rank for Alivus Life Sciences's FCF Margin % or its related term are showing as below:

NSE:ALIVUS' s FCF Margin % Range Over the Past 10 Years
Min: 0.08 Med: 11.33 Max: 22.3
Current: 13.08

During the past 6 years, the highest FCF Margin % of Alivus Life Sciences was 22.30%. The lowest was 0.08%. And the median was 11.33%.

NSE:ALIVUS's FCF Margin % is ranked better than
79.59% of 970 companies
in the Drug Manufacturers industry
Industry Median: 0.92 vs NSE:ALIVUS: 13.08

Alivus Life Sciences FCF Margin % Historical Data

The historical data trend for Alivus Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alivus Life Sciences FCF Margin % Chart

Alivus Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

9.63

17.20

22.30

6.99

13.02

Alivus Life Sciences Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Alivus Life Sciences's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Alivus Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alivus Life Sciences's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alivus Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alivus Life Sciences's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Alivus Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alivus Life Sciences's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	2845.46	/	21847.7
	=	13.02 %

Alivus Life Sciences's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	6418.44
	=	0.00 %

Alivus Life Sciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Alivus Life Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alivus Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (NSE:ALIVUS) » Definitions » FCF Margin %

Traded in Other Exchanges

543322:India

Address

470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099

Website

https://www.alivus.com

Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines